Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Music therapy may soothe anxiety in breast cancer patients

NCT ID NCT07483034

Symptom relief Sponsor: Brigita Vilc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether listening to calming classical music twice a day can help women with breast cancer feel less anxious and depressed during surgery and chemotherapy. Researchers will also check if music affects certain substances in the blood linked to stress and nerve health. Ninety women will be randomly assigned to either a music-listening group or a control group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
receptive music therapy (listening to classical instrumental music)
What this could lead to
If it works, this could offer a simple, drug-free way to ease anxiety and depression and improve quality of life for women with breast cancer during surgery and chemotherapy.
What could go wrong
This is an early study with only 90 participants, so results may not apply to all patients. The music selection is chosen by the researcher, not the patient, which may limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Breast Cancer (Ca mammae, C50), * Age: 18-65 years * Treatment at the University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia * Hospitalization during perioperative period while undergoing primary surgical removal of malignant neoplasm (segmentectomy or mastectomy with axillary lymph node dissection or sentinel lymph node biopsy; including possible reconstruction in the same surgery after mastectomy) * Administration of systemic oncological treatment - adjuvant chemotherapy (anthracycline or taxane-based cytostatics) * First occurrence of malignant disease * Early invasive breast cancer * Absence of metastases * Possible positive axillary lymph nodes * No history of hearing impairment Exclusion Criteria: * Presence of primary malignant process in other organs * Ductal carcinoma in situ * Previous malignant disease * Recurrence of Breast Cancer * Prior chemotherapy * Neoadjuvant chemotherapy * Diagnosis of anxiety and depressive disorders in the past three years * Other severe psychiatric disorders (bipolar disorder, schizophrenia) * Use of psychopharmacotherapy * Inability to read and write in Croatian * Presence of intellectual disabilities * Professional musicians (classical music) * Use of a hearing aid

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder breast cancer breast neoplasm Depression invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Breast cancer invasive Breast cancer surgery Chemotherapy Positive axillary lymph node

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Hospital for Tumors, Sestre Milosrdnice University Hospital Center Zagreb, Croatia

    Zagreb, City of Zagreb, 10000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.